Concord News Now

Epigenetics Market : Opportunities and Challenges

 Breaking News
  • No posts were found

Epigenetics Market : Opportunities and Challenges

October 25
18:10 2019
Epigenetics Market : Opportunities and Challenges

The prominent players in the global market are Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad Laboratories (US), New England Biolabs (US), Agilent (US), QIAGEN (Netherlands), Zymo Research (US), PerkinElmer (US), and Diagenode (Belgium).
The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases.

The global Epigenetics Market is projected to reach USD 1.60 billion by 2022 from USD 0.85 billion in 2016, at a CAGR of 13.3% from 2017 to 2022, as per a report by MarketsandMarkets. 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896

Why use of epigenetics in non-oncology applications opening new opportunities?

With the major hold of epigenetics in oncology, it is also being used to study modifications in various other applications, such as cardiovascular, neurodegenerative, autoimmune, and metabolic diseases. These diseases involve epigenetic modifications which can be counteracted by epigenetic treatments. These modifications seem an ideal target because they are reversible, unlike DNA sequence mutations. The most popular of these treatments aim to alter either DNA methylation or histone acetylation. Thus, a comprehensive understanding of epigenetic mechanisms and their interactions and alterations in health and diseases has become a priority in biomedical research.

Various government organizations support epigenetic studies that help understand the pathways and mechanisms of various diseases and disorders and facilitate the development of specific inhibitors. For instance, the NIH funded Rush University Medical Center’s (US) study aimed at exploring the role of the brain epigenome. Similarly, it supported the University of North Carolina (US) in the integrative analysis of open chromatin, epigenome, and transcriptome data for studying the molecular role of DNA variants associated with Crohn’s disease. Furthermore, the National Natural Science Foundation of China supported a research study aimed at analyzing the emerging role of epigenetics in autoimmune thyroid diseases, published in 2017.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=896

Why dearth of trained professionals remains a challenge?

Epigenetics is a relatively new field and requires experts with a good knowledge of its science and technology. The analysis of the colossal volume data generated in genomic research is a major challenge. Due to the high complexity involved and the need for in-depth knowledge, it is necessary to hire trained professionals to analyze and interpret the results of sequenced data. Owing to the shortage of trained professionals, a number of end users face significant challenges in analyzing sequenced data.

Browse Related Reports:

Research Antibodies Market by Product (Antibodies (Primary, Secondary)(Mouse, Rabbit)), Reagents), Technology (Western Blot, Flow Cytometry, Elisa, Immunofluorescence, Immunohistochemistry), Application, & End User – Global Forecast to 2022

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region – Global Forecast to 2022

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Shelly Singh
Email: Send Email
Phone: 1-888-600-6441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html